{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:31:19Z","timestamp":1785803479199,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010727","name":"Axel Muusfeldts Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.msard.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:23:02Z","timestamp":1559686982000},"page":"162-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008\u20122018: A nationwide, population-based cohort study"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2788-1974","authenticated-orcid":false,"given":"Magnus S.","family":"Boesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul E.H.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred P.","family":"Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Magyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hoei-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Blinkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Sellebjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2019.06.002_bib0001","first-page":"263","article-title":"The Danish national hospital register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan. Med. Bull."},{"issue":"10","key":"10.1016\/j.msard.2019.06.002_bib0002","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/CLEP.S156997","article-title":"Pediatric acquired demyelinating syndromes: a nationwide validation study of the Danish national patient register","volume":"2018","author":"Boesen","year":"2018","journal-title":"Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.msard.2019.06.002_bib0003","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/1352458517713669","article-title":"Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977\u20132015: a nationwide population-based incidence study","volume":"24","author":"Boesen","year":"2018","journal-title":"Mult. Scler. J."},{"issue":"11","key":"10.1016\/j.msard.2019.06.002_bib0004","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/dmcn.13798","article-title":"Implications of the International paediatric multiple sclerosis study group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation study","volume":"60","author":"Boesen","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.msard.2019.06.002_bib0005","first-page":"A4800","article-title":"Onset symptoms in paediatric multiple sclerosis","volume":"61","author":"Boesen","year":"2014","journal-title":"Dan. Med. J."},{"issue":"3","key":"10.1016\/j.msard.2019.06.002_bib0006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WCO.0000000000000551","article-title":"Mechanisms for lesion localization in neuromyelitis optica spectrum disorders","volume":"31","author":"Bradl","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2019.06.002_bib0007","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2019.06.002_bib0008","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","article-title":"Diagnostic algorithm for relapsing acquired demyelinating syndromes in children","volume":"89","author":"Hacohen","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2019.06.002_bib0009","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.msard.2019.06.002_bib0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"issue":"Pt 11","key":"10.1016\/j.msard.2019.06.002_bib0011","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2019.06.002_bib0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.msard.2019.06.002_bib0013","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.msard.2019.06.002_bib0014","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating Syndromes cohort","volume":"21","author":"Ketelslegers","year":"2015","journal-title":"Mult. Scler."},{"issue":"199","key":"10.1016\/j.msard.2019.06.002_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12424","article-title":"Registers of multiple sclerosis in Denmark","volume":"132","author":"Koch-Henriksen","year":"2015","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"2","key":"10.1016\/j.msard.2019.06.002_bib0016","first-page":"91","article-title":"The Danish multiple sclerosis registry. History, data collection and validity","volume":"48","author":"Koch-Henriksen","year":"2001","journal-title":"Dan. Med. Bull."},{"issue":"10","key":"10.1016\/j.msard.2019.06.002_bib0017","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2019.06.002_bib0018","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"issue":"9451","key":"10.1016\/j.msard.2019.06.002_bib0019","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"7 Suppl","key":"10.1016\/j.msard.2019.06.002_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.msard.2019.06.002_bib0021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CLEP.S99500","article-title":"The Danish multiple sclerosis treatment register","volume":"8","author":"Magyari","year":"2016","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.msard.2019.06.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","author":"Papp","year":"2018","journal-title":"Neurology"},{"issue":"7 Suppl","key":"10.1016\/j.msard.2019.06.002_bib0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"2","key":"10.1016\/j.msard.2019.06.002_bib0024","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2019.06.002_bib0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2019.06.002_bib0026","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.msard.2019.06.002_bib0027","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.msard.2019.06.002_bib0028","unstructured":"Statistikbanken[Internet]. [cited 2018 May 17]. Available from:https:\/\/www.statistikbanken.dk\/statbank5a\/default.asp?w=1920."},{"issue":"9 Suppl 2","key":"10.1016\/j.msard.2019.06.002_bib0029","first-page":"S8","article-title":"Consensus definitions for pediatric MS and other demyelinating disorders in childhood","volume":"87","author":"Tardieu","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2019.06.002_bib0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7 Suppl","key":"10.1016\/j.msard.2019.06.002_bib0031","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1403494811399956","article-title":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving","volume":"39","author":"Thygesen","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"9","key":"10.1016\/j.msard.2019.06.002_bib0032","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica","volume":"87","author":"Waters","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2019.06.002_bib0033","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.msard.2019.06.002_bib0034","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819302354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819302354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:46:02Z","timestamp":1761900362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819302354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"alternative-id":["S2211034819302354"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.06.002","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008\u20122018: A nationwide, population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}